Clayton Financial Group’s Mesoblast MESO Stock Holding History

Clayton Financial Group’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,893	Closed	-$173K	–	76
2025 Q1	$173K	Hold	13,893	–	–	0.06%	117
2024 Q4	$275K	Buy	+13,893	New	+$154K	0.1%	94

Other funds holding MESO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

SXL

Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Clayton Financial Group's MESO Position: Q2 2025 in Review

Clayton Financial Group sold out of Mesoblast (MESO) in Q2 2025, closing a stake of 13,893 shares — an estimated $173K sold.

Clayton Financial Group first reported a position in MESO in Q4 2024 and held it in 2 quarters. The position peaked at $275K in Q4 2024. 72 funds tracked by Wall St. Rank hold MESO as of Q2 2025.

Clayton Financial Group reported no remaining Mesoblast position as of Q2 2025 after selling out during the quarter.
Clayton Financial Group sold 13,893 Mesoblast shares in Q2 2025, an estimated $173K.
Clayton Financial Group first reported a position in Mesoblast in Q4 2024 and held it in 2 quarters.
Clayton Financial Group's Mesoblast position peaked at $275K in Q4 2024.
72 funds tracked by Wall St. Rank held Mesoblast as of Q2 2025.

Based on Clayton Financial Group's 13F filing for Q2 2025, filed 14 Jul 2025.